arrow
T

Thalia S. Field

University of British Columbia
H指数:47
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Radiological thrombus characteristics and the effect of tenecteplase versus alteplase on outcomes in acute ischemic stroke

急性缺血性卒中中放射学血栓特征以及替奈普酶与阿替普酶对预后的影响

2026-07-220
PRE
Venous Thrombotic and Thromboembolic Considerations in Stroke: An Expert Meeting Report on Future Directions for Clinical Trials

卒中中的静脉血栓形成和血栓栓塞问题:关于临床试验未来方向的专家会议报告

2026-07-190
PRE
Comparing Clinical Characteristics and Outcomes of Tenecteplase Versus Alteplase in Young Adult Patients With Stroke: A Secondary Analysis of the AcT Trial

比较替奈普酶与阿替普酶在青年卒中患者中的临床特征和结局:AcT试验的二次分析

2026-03-010
PRE
Publisher Correction: Anticoagulation to prevent ischemic stroke and neurocognitive impairment in atrial fibrillation: the BRAIN-AF randomized clinical trial

出版商更正: 抗凝预防房颤缺血性卒中和神经认知功能障碍: BRAIN-AF随机临床试验

2026-02-040
OAAI
Anticoagulation to prevent ischemic stroke and neurocognitive impairment in atrial fibrillation: the BRAIN-AF randomized clinical trial

抗凝预防房颤患者缺血性卒中和神经认知功能障碍: BRAIN-AF随机临床试验

2026-01-070
OAAI
Multiple Health Care Encounters Prior to Diagnosis of Cerebral Venous Thrombosis

在诊断为脑静脉血栓形成之前的多次医疗接触

2025-10-240
OAAI
Feasibility of telephone and computerized cognitive testing as a secondary outcome in an acute stroke clinical trial: A mixed methods sub-study of the AcT Trial

电话和计算机化认知测试作为急性卒中临床 trial 中次要结局的可行性:AcT Trial 的一项混合方法亚研究

2025-03-120
PRE
Misdiagnosis in Cervical Artery Dissection: Analysis of STOP-CAD Study

颈动脉夹层误诊:STOP-CAD研究分析

STROKE
IF8.9
2025-02-010
PRE
Factors Influencing Nerinetide Effect on Clinical Outcome in Patients Without Alteplase Treatment in the ESCAPE-NA1 Trial

影响ESCAPE-NA1试验中未接受阿替普酶治疗患者神经调节蛋白1疗效的临床因素

stroke
IF8.6
2025-01-310
OA
Thrombolysis in Patients With Versus Without Visible Occlusion: A Secondary Analysis From the AcT Trial

与无可见闭塞患者相比,有可见闭塞患者的溶栓治疗:来自AcT试验的二次分析

stroke
IF8.6
2025-01-310
OA
Safety and Efficacy of Intravenous Thrombolysis by Infarct Type in Patients with No Visible Occlusion: A Secondary Analysis of the AcT Trial
2025-01-070
PRE